These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1762643)

  • 1. Evaluating the cost-effectiveness of drug abuse treatment services.
    Apsler R
    NIDA Res Monogr; 1991; 113():57-66. PubMed ID: 1762643
    [No Abstract]   [Full Text] [Related]  

  • 2. Policy-relevant research on drug treatment.
    Gerstein DR
    NIDA Res Monogr; 1991; 113():129-47. PubMed ID: 1762636
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of drug abuse treatment: relevant issues and alternative longitudinal modeling approaches.
    Hser YI; Anglin MD
    NIDA Res Monogr; 1991; 113():67-93. PubMed ID: 1762644
    [No Abstract]   [Full Text] [Related]  

  • 4. Intensive case management for youth with serious emotional disturbance and chemical abuse.
    Evans ME; Dollard N
    NIDA Res Monogr; 1992; 127():289-315. PubMed ID: 1436000
    [No Abstract]   [Full Text] [Related]  

  • 5. Forecasting the cost of drug abuse treatment coverage in private health insurance.
    McGuire TG; Shatkin BF
    NIDA Res Monogr; 1991; 113():175-89. PubMed ID: 1762639
    [No Abstract]   [Full Text] [Related]  

  • 6. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and implementation of an interorganizational case management model for substance users.
    McCarthy EP; Feldman ZT; Lewis BF
    NIDA Res Monogr; 1992; 127():331-49. PubMed ID: 1436001
    [No Abstract]   [Full Text] [Related]  

  • 8. Case management as a mechanism for linking drug abuse treatment and primary care: preliminary evidence from the ADAMHA/HRSA linkage demonstration.
    Schlenger WE; Kroutil LA; Roland EJ
    NIDA Res Monogr; 1992; 127():316-30. PubMed ID: 1331803
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic costs, cost-effectiveness, financing, and community-based drug treatment.
    NIDA Res Monogr; 1991; 113():1-211. PubMed ID: 1762633
    [No Abstract]   [Full Text] [Related]  

  • 10. Financing treatment for substance abuse.
    Pauly MV
    NIDA Res Monogr; 1991; 113():165-74. PubMed ID: 1762638
    [No Abstract]   [Full Text] [Related]  

  • 11. New perspectives on the benefit-cost and cost-effectiveness of drug abuse treatment.
    Hubbard RL; French MT
    NIDA Res Monogr; 1991; 113():94-113. PubMed ID: 1762645
    [No Abstract]   [Full Text] [Related]  

  • 12. Case management systems represented in the NIDA-supported "Perinatal-20" treatment research demonstration projects.
    Rahdert ER
    NIDA Res Monogr; 1992; 127():251-60. PubMed ID: 1435998
    [No Abstract]   [Full Text] [Related]  

  • 13. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A research agenda for economic evaluation of substance abuse services.
    French MT; Drummond M
    J Subst Abuse Treat; 2005 Sep; 29(2):125-37. PubMed ID: 16135341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addiction research in a wealthy nation: is there an expanding German research presence?
    John U
    Addiction; 1995 May; 90(5):603-5. PubMed ID: 7795496
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effectiveness research in oncology: the need for clarity, transparency and vision.
    Lyman GH
    Cancer Invest; 2009 Jul; 27(6):593-7. PubMed ID: 19557579
    [No Abstract]   [Full Text] [Related]  

  • 17. TASC: case management models linking criminal justice and treatment.
    Cook F
    NIDA Res Monogr; 1992; 127():368-82. PubMed ID: 1436004
    [No Abstract]   [Full Text] [Related]  

  • 18. An analysis of substance abuse patterns, medical expenses and effectiveness of treatment in the workplace.
    Yu J; Chen PJ; Harshman EJ; McCarthy EG
    Empl Benefits J; 1991 Sep; 16(3):26-30. PubMed ID: 10170845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case management community advocacy for substance abuse clients.
    Ashery RS
    NIDA Res Monogr; 1992; 127():383-94. PubMed ID: 1436005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.